Literature DB >> 16397081

Does endoscopy diagnose early gastrointestinal cancer in patients with uncomplicated dyspepsia?

N Sundar1, V Muraleedharan, J Pandit, J T Green, R Crimmins, G L Swift.   

Abstract

BACKGROUND: Recent guidelines from NICE have proposed that open access gastroscopy is largely limited to patients with "alarm" symptoms. AIMS AND METHODS: This study reviewed the outcome of all our patients with verified oesophageal or gastric carcinoma who presented with uncomplicated dyspepsia to see if endoscopic investigation is warranted in this group. All patients with histologically verified upper gastrointestinal (GI) cancers who presented over a period from 1998 to 2002 were identified. Their presenting symptoms, treatment, and outcome were analysed.
RESULTS: 228 upper GI cancers (119 oesophageal, 109 gastric; mean age 72 years (29-99 years); 130 male, 82 female) were identified in 11 145 endoscopies performed. Only 14 patients (6.2%) presented without alarm symptoms; three patients were under 55 years of age and all had gastric carcinoma-one of these had chronic diarrhoea only. Eleven had dyspepsia or reflux symptoms only, and two were under surveillance for Barrett's oesophagus. Only five patients had a curative surgical resection and are still alive two-six years from diagnosis. A sixth patient had a curative operation but died of a cerebrovascular accident one year later. The remaining eight patients unfortunately had either metastatic disease or comorbidity, which precluded surgery. All of these died within two years of diagnosis, mean survival 10 months.
CONCLUSION: Only five patients with dyspepsia and no alarm symptoms had resectable upper GI malignancies over a four year period. Limiting open access gastroscopy to those with alarm features only would "miss" a small number of patients who have curable upper GI malignancy.

Entities:  

Mesh:

Year:  2006        PMID: 16397081      PMCID: PMC2563735          DOI: 10.1136/pgmj.2005.034033

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  15 in total

1.  Do young patients with dyspepsia need investigation?

Authors:  B Williams; M Luckas; J H Ellingham; A Dain; A C Wicks
Journal:  Lancet       Date:  1988-12-10       Impact factor: 79.321

Review 2.  Chronic dyspepsia: who needs endoscopy?

Authors:  A T Axon
Journal:  Gastroenterology       Date:  1997-04       Impact factor: 22.682

3.  Predictive value of alarm features in a rapid access upper gastrointestinal cancer service.

Authors:  N Kapoor; A Bassi; R Sturgess; K Bodger
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

4.  Evaluation of the dyspeptic patient: a cost-utility study.

Authors:  M H Ebell; L Warbasse; C Brenner
Journal:  J Fam Pract       Date:  1997-06       Impact factor: 0.493

Review 5.  Endoscopy in the evaluation of dyspepsia. Health and Public Policy Committee, American College of Physicians.

Authors: 
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

6.  Upper GI malignancy, uncomplicated dyspepsia, and the age threshold for early endoscopy.

Authors:  Cristino Canga; Nimish Vakil
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

7.  Prescribing patterns for dyspepsia in primary care: a prospective study of selected general practitioners.

Authors:  K Bodger; M J Daly; R V Heatley
Journal:  Aliment Pharmacol Ther       Date:  1996-12       Impact factor: 8.171

8.  Guidelines on appropriate indications for upper gastrointestinal endoscopy. Working Party of the Joint Committee of the Royal College of Physicians of London, Royal College of Surgeons of England, Royal College of Anaesthetists, Association of Surgeons, the British Society of Gastroenterology, and the Thoracic Society of Great Britain.

Authors:  A T Axon; G D Bell; R H Jones; M A Quine; R F McCloy
Journal:  BMJ       Date:  1995-04-01

9.  Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori Study Group.

Authors:  D Vaira; V Stanghellini; M Menegatti; D Palli; R Corinaldesi; M Miglioli
Journal:  Endoscopy       Date:  1997-09       Impact factor: 10.093

10.  Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia.

Authors:  P Bytzer; J M Hansen; O B Schaffalitzky de Muckadell
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

View more
  6 in total

1.  Managing dyspepsia in a primary care setting.

Authors:  A Kenneth Musana; Steven H Yale; Kevin A Lang
Journal:  Clin Med Res       Date:  2006-12

2.  Upper gastrointestinal cancer in its early stages is predominantly asymptomatic.

Authors:  James W Berrill; Jeff K Turner; Jo J Hurley; Gillian Swift; Sunil Dolwani; John T Green
Journal:  Frontline Gastroenterol       Date:  2011-09-10

3.  Systematic review with meta-analysis: age-related malignancy detection rates at upper gastrointestinal endoscopy.

Authors:  Judith J de Jong; Marten A Lantinga; Ina M E Thijs; Philip R de Reuver; Joost P H Drenth
Journal:  Therap Adv Gastroenterol       Date:  2020-11-04       Impact factor: 4.409

Review 4.  Role of symptoms in diagnosis and outcome of gastric cancer.

Authors:  Giovanni Maconi; Gianpiero Manes; Gabriele-Bianchi Porro
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

5.  A Simple Pre-endoscopy Score for Predicting Risk of Malignancy in Patients with Dyspepsia: A 5-Year Prospective Study.

Authors:  Amit Kumar Dutta; Grace Rebekah; Sudipta Dhar Chowdhury; Sajith Kattiparambil Gangadharan; Yuvaraj Subramani; Manoj Kumar Sahu; Reuben Thomas Kurien; Deepu David; Ebby George Simon; Anjilivelil Joseph Joseph; Viswanath Reddy Donapati; Ashok Chacko
Journal:  Dig Dis Sci       Date:  2018-08-14       Impact factor: 3.199

6.  Usefulness of a fast track list for anxious patients in a upper GI endoscopy.

Authors:  Fabrizio Cardin; Alessandra Andreotti; Manuel Zorzi; Claudio Terranova; Bruno Martella; Bruno Amato; Carmelo Militello
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.